stroke volume, cardiac output, cardiac power output, peak flow, peak flow acceleration, aortic back flow, and flow wave velocity. Heart rate, blood pressure, double product, and maximum tolerated dobutamine dose were also measured. Multiple regression analysis was used to compare changes during stress with "'"TI tomography. Results-All parameters except for stroke volume and diastolic blood pressure increased in the controls. In the patients with CAD a significant relation was shown between the extent of reversible ischaemia and the change in peak flow acceleration (P < 0.00001), peak flow (P = 0.002), cardiac power output (P = 0.036), maximum dobutamine dose (P = 0.039), and systolic blood pressure (P = 0.04).
Abstract
Background-Magnetic resonance imaging (MRI) is a versatile technique for examination of the cardiovascular system but only recently has assessment of myocardial ischaemia in coronary artery disease (CAD) become possible, for example by demonstrating abnormalities of regional ventricular contraction during stress. Global ventricular function during stress was assessed by MRI of aortic flow, which has not been previously attempted. Design-Variables measured by MRI reflecting the effect of ischaemia on global ventricular function during dobutamine stress were correlated with thallium-201 myocardial perfusion tomography. Patients-10 normal controls and 25 patients with CAD. Setting-Tertiary cardiac referral centre. Methods-Novel MRI sequences and analysis systems were used to measure the following variables during staged dobutamine infusion to 20 1uglkglmin: stroke volume, cardiac output, cardiac power output, peak flow, peak flow acceleration, aortic back flow, and flow wave velocity. Heart rate, blood pressure, double product, and maximum tolerated dobutamine dose were also measured. Multiple regression analysis was used to compare changes during stress with "'"TI tomography. Results-All parameters except for stroke volume and diastolic blood pressure increased in the controls. In the patients with CAD a significant relation was shown between the extent of reversible ischaemia and the change in peak flow acceleration (P < 0.00001), peak flow (P = 0.002), cardiac power output (P = 0.036), maximum dobutamine dose (P = 0.039), and systolic blood pressure (P = 0.04).
Peak flow acceleration accounted for 58-4% of the variation in reversible ischaemia, and after allowing for this, only cardiac power output remained independently predictive adding a fiwther 4-2% to the model (adjusted r' = 0.626). A decrease in peak flow acceleration with an increase in dobutamine infusion indicated moderate or severe ischaemia (2 = 10-2, P = 0-017).
Conclusion-MRI may be used to assess variables of aortic flow during stress, which includes acceleration with high temporal resolution. Peak flow acceleration was the most sensitive indicator of the effect of ischaemia on global ventricular function. (Br HeartJa 1995; 74:163-170) Keywords: magnetic resonance imaging; coronary artery disease; ventricular function; dobutamine infusion
The functional significance of coronary artery disease (CAD) may be studied by the assessment of myocardial perfusion, regional left ventricular wall motion, or haemodynamic variables reflecting global left ventricular ejection. The prognostic importance of functional abnormality in CAD is well described,' and at least equivalent to coronary arteriography."
Magnetic resonance imaging (MRI) is a new technique for investigating the heart, but studies in CAD are few, and to date have involved the assessment of infarction,4 changes in regional ventricular contraction during dipyridamole5 or dobutamine,6 and preliminary coronary angiography7 8 fig 1) . Assessment of magnetic resonance velocity mapping ofglobal ventricularfunction during dobutamine infusion in coronary artery disease ated only from pixels with retrograde flow ( fig  5) .23 Cardiac output was derived from the product of stroke volume and heart rate and cardiac power output was estimated from the product of cardiac output and mean blood pressure (BP), calculated as diastolic blood pressure plus one third the pulse pressure, with a correction for the estimated mean right atrial pressure (RAP) according to the equation21:
Cardiac power output (W) = cardiac output (1/min) x (mean BP -mean RAP) x 0-00222 Flow acceleration was calculated by fitting the instantaneous flow measurements from the higher temporal resolution acquisition with a four harmonic Fourier function and differentiating the fitted curve ( fig 6) . The time for the foot of the flow wave to travel between the ascending and descending aorta was also measured from these fitted curves and used to compute flow wave velocity ( fig 7) .
The thallium tomograms were analysed visually by dividing the myocardium into nine segments (anterior, lateral, inferior, septal, each with apical and basal portions, and the apex). Activity in each segment was assessed semiquantitatively using a five point scale from 0 (absent) to 4 (normal). A change in score of one or more between stress and redistribution images was defined as redistribution. Abnormal segments without change or with a reduction in score were defined as fixed defects. Time after R wave (ms) Coronary angiograms were analysed visually without knowledge of magnetic resonance or thallium findings. A significant stenosis was defined as a diameter reduction of more than 50% compared with that of an adjacent normal segment.
STATISTICAL ANALYSIS
The differences in age between the normal volunteers and the patients were analysed using an unpaired t test, and differences of gender using the x2 test. The distribution of the number of reversibly ischaemic thallium segments according to the number of diseased coronary arteries was analysed using Spearman's rank correlation coefficient. The correlation between age and the change from baseline to peak stress in the haemodynamic variables was examined using linear regression analysis. The changes in haemodynamic variables at each stage of dobutamine infusion were analysed using analysis of variance with repeated measures, which treated the dose levels as unordered factors. The relation between the change in haemodynamic variables from baseline to peak stress and the extent of reversible ischaemia was first examined by univariate regression analysis and subsequently by a forward stepwise multiple regression analysis. Comparisons between variables from baseline to peak stress were made using the paired t test. Comparisons between groups with or without a fall in peak flow acceleration were made with the X2 test. the penultimate and final stages of stress was however predictive of ischaemia, most significantly peak flow acceleration. A decrease in peak flow acceleration at peak stress was more common with severe (more than four segments) or moderate (three to four segments) ischaemia than with mild ischaemia (one to two segments) or in normal controls ( Table 4 gives the results of univariate regression analysis between extent of myocardial ischaemia and change in each haemodynamic variable from baseline and peak stress in patients with CAD. There were significant correlations for peak flow acceleration, peak flow, cardiac power output, maximum dose tolerated, and systolic blood pressure. Forward stepwise linear regression analysis showed that the most significant variable was the change in peak flow acceleration (F = 32-3, r =-0-764, P < 0-00001) which accounted for 58-4% of the variation in the extent of reversible ischaemia (table 5) . After allowing for this the only other variable with independent significance was cardiac power output (F = 4 7, P = 0 042), but its additional contribution to the model was only 4-2% (combined adjusted partial r2 = 0 626). Figure 8 shows the change in peak flow acceleration plotted against the extent of reversible ischaemia. Although there was a good correlation with the extent of reversible ischaemia, it was not possible in most cases to distinguish patients with mild reversible ischaemia from those without ischaemia. There was a correlation between the extent of the thallium perfusion defect and the number of diseased coronary arteries (rs = 0 40, P = 0-05) with the mean (range) number of segments with reversible ischaemia in zero, one, two, and three vessel disease being 1-7 (0-5), 2-3 (1-5), 3-6 (1-7), and 6-3 (5-7) Qw main exceptions of diastolic blood pressure which was unchanged, systolic blood pressure which rose to a plateau, and stroke volume which rose and then declined. The group response of patients with CAD did not show significant differences from these results because of the variable dobutamine dose tolerated. Therefore, analysis of the change from baseline to peak stress for each variable was more useful, and correlation was performed with the extent of ischaemia, because greater changes in global ventricular function would be expected in those with greatest ischaemia. This analysis showed that peak flow acceleration was the variable most closely correlated with the extent of reversible myocardial ischaemia. In addition, when peak flow acceleration decreased despite an increasing dose of dobutamine, moderate or severe ischaemia was likely to be present. While other variables were predictive of ischaemia by themselves (peak flow, cardiac power output, maximum dobutamine dose, and systolic blood pressure), their significance was low or none in the multiple regression model after acceleration was introduced. There was an inverse relation between the increase in peak flow acceleration during stress and the extent of ischaemia (fig 8) , which suggested that severity of the abnormality may be graded, but there was significant scatter and overlap between the normal response and that of mild ischaemia. This suggests that acceleration may be insensitive to low level ischaemia.
ANIMAL STUDIES OF AORTIC ACCELERATION
Acceleration of aortic flow is generated by ventricular contraction and is related to the velocity of myocardial shortening,27 which is a variable reflecting myocardial contractility. exercise also declines with age, however,44 and thus reasonably stable values of the change between rest and stress might be expected. Although this study is not sufficiently large to confirm this, no relation could be demonstrated between age and change in peak flow acceleration in normal controls.
The control group used in this study was less than ideal because of the relatively limited investigations regarding the absence of coronary artery disease other than history and examination. Any covert ischaemia would be expected to dilute the differences observed between patients and normal controls. Comparison between controls and patients was associated with low statistical power because of the small number of normal volunteers. In addition, segmental analysis of ischaemia used in multiple regression analysis hindered interpretation of the predictive value of the haemodynamic variables, and there was considerable variation in the change in peak flow acceleration compared with that in the extent of ischaemia. It is important to note, however, that this study was primarily designed to investigate the feasibility of aortic flow imaging during dobutamine stress as a new technique, and while the promising results do not suggest that such a test could be used clinically at present, they are sufficiently encouraging to indicate that further more refined studies might be rewarding. 
